Zhitong Finance App News, Sinopharm Hyundai (600420.SH) announced that the company expects to achieve net profit attributable to shareholders of listed companies of 296 million yuan to 326 million yuan in the first three quarters of 2026, a year-on-year decrease of 59.30% to 63.05%.

The pharmaceutical sector is affected by price reductions linked to procurement and increased competition in the product market, and the revenue scale continues to be under pressure. Although the company relied on scale advantages to actively promote quality and efficiency, and the gross margin of the sector increased 1.89 percentage points year over year, it is still difficult to fully offset the adverse effects of the decline in sales scale.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.